Importance of high-density lipoprotein-cholesterol (HDL-C) levels to the incidence of cardiovascular disease (CVD) in the elderly

This publication has 23 references indexed in Scilit:

• Cardiovascular Risk Factors Predictive for Survival and Morbidity‐Free Survival in the Oldest‐Old Framingham Heart Study Participants
  Journal of the American Geriatrics Society, 2005
• Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study
  The Lancet, 2004
• High Density Lipoprotein Cholesterol and the Risk of Stroke in Elderly Men: The Honolulu Heart Program
  American Journal of Epidemiology, 2004
• Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
  Hypertension, 2003
• MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
  The Lancet, 2002
• Secondary Prevention of Coronary Heart Disease in the Elderly (With Emphasis on Patients ≥75 Years of Age)
  Circulation, 2002
• Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
  JAMA, 2001
• 1999 George Lyman Duff Memorial Lecture
  Arteriosclerosis, Thrombosis, and Vascular Biology, 2000
• The design of a prospective study of pravastatin in the elderly at risk (PROSPER)
  The American Journal of Cardiology, 1999
• Correlation of serum lipids with the presence or absence of coronary artery disease in 1,793 men and women aged ≥ 62 years
  The American Journal of Cardiology, 1994